AnaBios has established methodologies that consistently allow the procurement and experimental interrogation of human heart tissue preparations to provide a much-needed integrative preclinical model to reliably assess the toxicity risk of new drugs. These novel methodologies include scalable ex-vivo heart models from the isolation of adult human primary cardiomyocytes.

PUBLICATION: Journal of Pharmacological and Toxicological Methods (2017)

AUTHORS: Nathalie Nguyen, Yannick Miron, Phachareeya Ratchada, Guy Page, Paul E. Miller, Andre Ghetti and Najah Abi-Gerges